Home Biosimilar Antibodies Stem Cells & Wnt Wnt/beta-catenin antibody Vantictumab (Anti-FZD) For research use only.
Not for use in humans.

Vantictumab (Anti-FZD)

Synonyms: OMP-18R5

Vantictumab (Anti-FZD) is a monoclonal antibody targeting the Wnt signaling pathway with potential antineoplastic activity. Vantictumab binds to certain receptors in the Wnt signaling pathway thereby preventing the activation of the Wnt signaling pathway. This results in an inhibition of cancer stem cell (CSC) activity and a subsequent inhibition of cancer cell proliferation. MW: 145.5 KD.

Vantictumab (Anti-FZD)

Purity & Quality Control

Batch: A248901 Purity: 99% Protein concentration: 5.82mg/ml Endotoxin Level: ＜1EU/mg
99

Choose Selective Wnt/beta-catenin Inhibitors

Biological Activity

Description Vantictumab (Anti-FZD) is a monoclonal antibody targeting the Wnt signaling pathway with potential antineoplastic activity. Vantictumab binds to certain receptors in the Wnt signaling pathway thereby preventing the activation of the Wnt signaling pathway. This results in an inhibition of cancer stem cell (CSC) activity and a subsequent inhibition of cancer cell proliferation. MW: 145.5 KD.

Product Details

CAS No. 1345009-45-1
Molecular Weight 145.5 kDa
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Vantictumab (Anti-FZD) | Vantictumab (Anti-FZD) supplier | purchase Vantictumab (Anti-FZD) | Vantictumab (Anti-FZD) cost | Vantictumab (Anti-FZD) manufacturer | order Vantictumab (Anti-FZD) | Vantictumab (Anti-FZD) distributor